The Burden of Pathological Neonatal Jaundice and Its Determinants in Ethiopia: Systematic Review and Meta-Analysis. Issue 2 (June 2023)

• Record Type: Journal Article
• Authors: Tsehay, Binalfew; Afework, Mekbeb
• Is Part Of: Journal of neonatology. Volume 37:Issue 2(2023)
• Page Start: 108
• Page End: 118
• Publication Date: 2023-06
• Subjects: Hyperbilirubinemia -- neonates -- RH isoimmunization -- ABO incompatibility; Neonatology -- Periodicals; Neonatology -- India -- Periodicals; 618.9201
• DOI: 10.1177/09732179231164520
• Languages: English
• ISSNs: 0973-2179

Abstract

Background: Neonatal hyperbilirubinemia is a common clinical problem encountered during the neonatal period, especially in the first week of life. Available clinical guidelines note that early detection and intervention of infants at risk of severe hyperbilirubinemia can facilitate timely and effective prevention of the associated complications. Methods: The international databases, PubMed/MEDLINE, EMBASE, CINAHL, Google Scholar, Science Direct, and Cochrane Library, and unpublished reports were systematically searched. Two authors independently extracted all necessary data using a standardized data extraction format. STATA 14 statistical software was employed to analyze the data. The Cochrane Q test statistics and I 2 tests were used to assess the heterogeneity between the studies. A random-effect model was computed to estimate the pooled prevalence of pathological neonatal hyperbilirubinemia in Ethiopia. Determinants of neonatal hyperbilirubinemia were analyzed. Results: Ten studies fulfilled the inclusion criteria and were included in the meta-analysis. The I 2 test result showed high heterogeneity (I 2, 98.3%, P = <.001). Using the random effect analysis, the pooled prevalence of neonatal hyperbilirubinemia in Ethiopia was 35.90% (95% confidence interval [CI] [23.79, 48.01]). The results from these studies revealed that the occurrence of pathological neonatal hyperbilirubinemia was significantly associated with the presence of ABO blood incompatibility, Rh isoimmunization, neonatal sepsis (odds ratio [OR]: 4.44; CI: 1.72, 11.46), birth asphyxia (OR:1.74; CI: 1.08, 2.80), low birth weight (OR: 2.22; CI: 1.46, 3.31), and prolonged labor (OR: 3.24; CI: 1.05, 10.0). Conclusion: The burden of neonatal hyperbilirubinemia is higher in our country as compared with others. ABO blood incompatibility, Rh isoimmunization, neonatal sepsis, birth asphyxia, low birth weight, and prolonged labor were significantly associated with neonatal hyperbilirubinemia.